Infliximab (anti-TNF-alpha) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α, prevents the interaction of TNF-α with TNF-α receptor (TNFR1 and TNFR2), has the potential for treatment of Crohn's disease and rheumatoid arthritis.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
Specification: ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/I412009-SCI_f028c77a52b56a41d7c850f19122fcf1.pdf
- UPC:
- 51383903
- Condition:
- New
- Availability:
- 5-10 days
- Weight:
- 0.07 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- I412009-100μg
- CAS:
- 170277-31-3
- Product Size:
- 100μg